mutations offered The reality that, as stated under, CLL therapy is predicated within the existence or absence of these mutations. The present consensus is the fact, aside from clonal mutations, subclonal mutations having a variant allelic frequency ranging from five to ten% (and for that reason down below the edge of detection by typical molecular